This funding opportunity supports innovative research to advance open- and closed-loop diabetes control systems. Funded projects may focus on novel sensing technologies, hormone delivery methods, AI and machine learning algorithms, and digital twin modeling to enhance automated control and decision support. The goal is to improve glycemic control, reduce care burden, and enhance quality of life for individuals with type 1 diabetes. Clinical trials are optional.
Eligible applicants include U.S. city, county, state, and tribal governments, nonprofits, institutions of higher education, for-profit organizations (excluding small businesses), small businesses, independent school districts, and public housing authorities. Eligibility is broad across government an
